GE Aerospace

Abbott Laboratories

Freeport-McMoRan

Huntington Bancshares

The Procter & Gamble

Pre-Market Earnings Report for January 22, 2026: PG, GE, ABT, FCX, HBAN, NTRS, MKC, ORI, CADE, AUB, TCBI, NG.

Freeport-McMoRan Q4 Earnings Preview: Analysts Optimistic

Investors Weigh FCX vs. BHP: Which Copper Mining Giant Reigns Supreme?

Freeport-McMoRan's Valuation Under Scrutiny Amid Copper and Gold Surge

Agnico Eagle Mines

Cameco

Bank of America's Top 3 Metals Stocks to Watch in 2026

Catalyst<ul> <li>Most analysts rate FCX Buy or Strong Buy, showing broad institutional optimism.</li></ul>Risk<ul> <li>Technical indicators show that the market is in a weak state, and we need to pay attention to the risk of decline.</li> <li>Recent RSI Overbought signals and a Hanging Man pattern highlight ongoing bearish bias in technical indicators.</li> <li>Analyst ratings show differences, with some maintaining cautious or neutral expectations for FCX.</li></ul>

Key Factors

Freeport-McMoRan (FCX) reported Q3 2025 earnings of $0.50 per share, exceeding the $0.41 forecast by 21.95%, with revenue of $6.97 billion. FCX is expected to report Q4 2025 earnings of $0.32 per share on January 22, 2026, representing a 3.2% year-over-year increase. Freeport-McMoRan expanded its concentrator at Cerro Verde in Peru and is conducting pre-feasibility studies for a sulfide expansion at Safford/Lone Star in Arizona. FCX’s stock surged 2.32% on January 20, 2026, with a trading volume of $1.15 billion on the NYSE.

Recent Updates

FCX News